drugset / Trial / NCT02978144

Lung Imaging of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)

NCT02978144 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

This is a prospective interventional study examining the use of Annexin - a radioactive tracer, in assessing lung damage in healthy volunteers, healthy volunteers actively smoking, and patients with moderate and severe chronic obstructive pulmonary disease (COPD). All study participants will undergo a CT scan, pulmonary testing, and blood test. The study procedures are done in one day. The aim of this study is to determine if Annexin can be used as a marker to detect lung injury early on and aid in the future diagnosis of COPD.

Timeline

Start
2017-06-15
Primary completion
2019-10-08
Completion
2019-10-08

Outcome

Outcome not reported

Stopped: “Difficulty finding Annexin study drug supplier”

Drugs

EvaluationDrugModalityDoseRoute
Subject AxV-128/Tc Diagnostic / imaging agent — Intravenous